BE540998A - - Google Patents
Info
- Publication number
- BE540998A BE540998A BE540998DA BE540998A BE 540998 A BE540998 A BE 540998A BE 540998D A BE540998D A BE 540998DA BE 540998 A BE540998 A BE 540998A
- Authority
- BE
- Belgium
- Prior art keywords
- hormone
- insulin
- extract
- alcohol
- pancreatic
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 102000004877 Insulin Human genes 0.000 claims description 10
- 108090001061 Insulin Proteins 0.000 claims description 10
- 229940125396 insulin Drugs 0.000 claims description 10
- 210000001034 respiratory center Anatomy 0.000 claims description 8
- 229940088597 hormone Drugs 0.000 claims description 7
- 239000005556 hormone Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 230000003345 hyperglycaemic effect Effects 0.000 claims description 5
- 239000000276 potassium ferrocyanide Substances 0.000 claims description 5
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 4
- 239000000287 crude extract Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 230000002427 irreversible effect Effects 0.000 claims description 3
- 210000000496 pancreas Anatomy 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 5
- 102000052651 Pancreatic hormone Human genes 0.000 description 3
- 101800001268 Pancreatic hormone Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 239000004025 pancreas hormone Substances 0.000 description 3
- 229940032957 pancreatic hormone Drugs 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE540998A true BE540998A (enrdf_load_stackoverflow) |
Family
ID=170164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE540998D BE540998A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE540998A (enrdf_load_stackoverflow) |
-
0
- BE BE540998D patent/BE540998A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2703049A1 (fr) | Procédé de purification des taxoïdes. | |
| FR2964570A1 (fr) | Procede de preparation d'un extrait de centella asiatica | |
| BE540998A (enrdf_load_stackoverflow) | ||
| EP1511726B1 (fr) | Procede de preparation de 1,3,5-triaminobenzene et son hydrolyse en phloroglucinol de haute purete | |
| Power et al. | XCI.—The constituents of the seeds of Hydnocarpus Wightiana and of Hydnocarpus anthelmintica. Isolation of a homologue of chaulmoogric acid | |
| Glattfeld et al. | The preparation of aldonic and saccharinic acid amides in liquid ammonia | |
| EP0023178B1 (fr) | Procédé de préparation de solutions concentrées d'amygdaline sous sa forme naturelle | |
| CH394488A (fr) | Procédé de préparation d'antigènes cellulaires | |
| JPH0694434B2 (ja) | １０−ヒドロキシ−δ−２−デセン酸の製法 | |
| CH332662A (fr) | Procédé de préparation d'émétine | |
| BE689679A (enrdf_load_stackoverflow) | ||
| FR2106M (enrdf_load_stackoverflow) | ||
| JPH04149134A (ja) | アロエエキスの苦味成分を分離する方法 | |
| BE445966A (enrdf_load_stackoverflow) | ||
| BE349707A (enrdf_load_stackoverflow) | ||
| BE635463A (enrdf_load_stackoverflow) | ||
| BE448597A (enrdf_load_stackoverflow) | ||
| BE475216A (enrdf_load_stackoverflow) | ||
| EP0524082A1 (fr) | Procédé de préparation du cis-inositol, du méso-inositol, de l'épi-inositol et/ou du cis-quercitol éventuellement deutérés | |
| BE501271A (enrdf_load_stackoverflow) | ||
| CH291374A (fr) | Procédé de préparation d'une composition thérapeutique stable et limpide, à action antibiotique. | |
| FR2552767A1 (fr) | Procede de preparation de la digoxine | |
| BE640827A (enrdf_load_stackoverflow) | ||
| McMath et al. | LXXX.—The optical resolution of chloroiodoacetic acid | |
| JPS63170343A (ja) | ロイシンの分離方法 |